These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 9129152

  • 1. Mob-1, a Ras target gene, is overexpressed in colorectal cancer.
    Zhang R, Zhang H, Zhu W, Pardee AB, Coffey RJ, Liang P.
    Oncogene; 1997 Apr 03; 14(13):1607-10. PubMed ID: 9129152
    [Abstract] [Full Text] [Related]

  • 2. [Farnesyl transferase inhibitors: one target may be found in another].
    Mazières J, Pradines A, Favre G.
    Med Sci (Paris); 2003 Feb 03; 19(2):211-6. PubMed ID: 12836615
    [Abstract] [Full Text] [Related]

  • 3. Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors.
    Prendergast GC, Davide JP, Lebowitz PF, Wechsler-Reya R, Kohl NE.
    Cancer Res; 1996 Jun 01; 56(11):2626-32. PubMed ID: 8653708
    [Abstract] [Full Text] [Related]

  • 4. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J, Jiang B, Coffey RJ, Barnard J.
    Mol Cancer Res; 2004 Apr 01; 2(4):233-41. PubMed ID: 15140945
    [Abstract] [Full Text] [Related]

  • 5. Perspectives on farnesyl transferase inhibitors in cancer therapy.
    Mazieres J, Pradines A, Favre G.
    Cancer Lett; 2004 Apr 08; 206(2):159-67. PubMed ID: 15013521
    [Abstract] [Full Text] [Related]

  • 6. Ischemia-induced K-ras mutations in human colorectal cancer cells: role of microenvironmental regulation of MSH2 expression.
    Shahrzad S, Quayle L, Stone C, Plumb C, Shirasawa S, Rak JW, Coomber BL.
    Cancer Res; 2005 Sep 15; 65(18):8134-41. PubMed ID: 16166287
    [Abstract] [Full Text] [Related]

  • 7. Elevation of alpha2(I) collagen, a suppressor of Ras transformation, is required for stable phenotypic reversion by farnesyltransferase inhibitors.
    Du W, Lebowitz PF, Prendergast GC.
    Cancer Res; 1999 May 01; 59(9):2059-63. PubMed ID: 10232587
    [Abstract] [Full Text] [Related]

  • 8. Ras activation of genes: Mob-1 as a model.
    Liang P, Averboukh L, Zhu W, Pardee AB.
    Proc Natl Acad Sci U S A; 1994 Dec 20; 91(26):12515-9. PubMed ID: 7809069
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effect of a farnesyl protein transferase inhibitor in mammary and lymphoid tumors overexpressing N-ras in transgenic mice.
    Mangues R, Corral T, Kohl NE, Symmans WF, Lu S, Malumbres M, Gibbs JB, Oliff A, Pellicer A.
    Cancer Res; 1998 Mar 15; 58(6):1253-9. PubMed ID: 9515813
    [Abstract] [Full Text] [Related]

  • 10. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY, Wang YH, Jao SW, Lu CY, Kuo CH, Hu HM, Hsieh JS, Chong IW, Cheng TL, Lin SR.
    Oncol Rep; 2006 Dec 15; 16(6):1245-52. PubMed ID: 17089045
    [Abstract] [Full Text] [Related]

  • 11. The up-regulation of vascular endothelial growth factor in mutated Ha-ras HaCaT cell lines is reduced by a farnesyl transferase inhibitor.
    Charvat S, Duchesne M, Parvaz P, Chignol MC, Schmitt D, Serres M.
    Anticancer Res; 1999 Dec 15; 19(1A):557-61. PubMed ID: 10226598
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
    Seiden-Long IM, Brown KR, Shih W, Wigle DA, Radulovich N, Jurisica I, Tsao MS.
    Oncogene; 2006 Jan 05; 25(1):91-102. PubMed ID: 16158056
    [Abstract] [Full Text] [Related]

  • 13. Expression and regulation of the CXC-chemokines, GRO/KC and IP-10/mob-1 in rat seminiferous tubules.
    Aubry F, Habasque C, Satie AP, Jégou B, Samson M.
    Eur Cytokine Netw; 2000 Dec 05; 11(4):690-8. PubMed ID: 11125315
    [Abstract] [Full Text] [Related]

  • 14. c-myc down-regulation induces apoptosis in human cancer cell lines exposed to RPR-115135 (C31H29NO4), a non-peptidomimetic farnesyltransferase inhibitor.
    Russo P, Arzani D, Trombino S, Falugi C.
    J Pharmacol Exp Ther; 2003 Jan 05; 304(1):37-47. PubMed ID: 12490573
    [Abstract] [Full Text] [Related]

  • 15. Farnesyltransferase inhibitors reverse Ras-mediated inhibition of Fas gene expression.
    Zhang B, Prendergast GC, Fenton RG.
    Cancer Res; 2002 Jan 15; 62(2):450-8. PubMed ID: 11809695
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM, Lau N, Guha A.
    Oncogene; 1999 Dec 09; 18(52):7514-26. PubMed ID: 10602510
    [Abstract] [Full Text] [Related]

  • 17. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
    Alcock RA, Dey S, Chendil D, Inayat MS, Mohiuddin M, Hartman G, Chatfield LK, Gallicchio VS, Ahmed MM.
    Oncogene; 2002 Nov 07; 21(51):7883-90. PubMed ID: 12420225
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB, Omer CA, Abrams MT, Bhimnathwala HG, Brucker MJ, Buser CA, Davide JP, deSolms SJ, Dinsmore CJ, Ellis-Hutchings MS, Kral AM, Liu D, Lumma WC, Machotka SV, Rands E, Williams TM, Graham SL, Hartman GD, Oliff AI, Heimbrook DC, Kohl NE.
    Cancer Res; 2001 Dec 15; 61(24):8758-68. PubMed ID: 11751396
    [Abstract] [Full Text] [Related]

  • 19. Mouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor.
    Omer CA, Chen Z, Diehl RE, Conner MW, Chen HY, Trumbauer ME, Gopal-Truter S, Seeburger G, Bhimnathwala H, Abrams MT, Davide JP, Ellis MS, Gibbs JB, Greenberg I, Koblan KS, Kral AM, Liu D, Lobell RB, Miller PJ, Mosser SD, O'Neill TJ, Rands E, Schaber MD, Senderak ET, Oliff A, Kohl NE.
    Cancer Res; 2000 May 15; 60(10):2680-8. PubMed ID: 10825141
    [Abstract] [Full Text] [Related]

  • 20. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
    Vasseur S, Malicet C, Calvo EL, Labrie C, Berthezene P, Dagorn JC, Iovanna JL.
    Mol Cancer; 2003 Mar 19; 2():19. PubMed ID: 12685932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.